University of Münster
CRIS@UM
DE | EN

Stefan Bierer

No current affiliations available for this person. The person is no longer active at the university.

Publications

Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib.
Riesenbeck LM, Bierer S, Hoffmeister I, Köpke T, Papavassilis P, Hertle L, Thielen B, Herrmann E (2011)
In: World Journal of Urology, 29(6), 807-813. doi:10.1007/s00345-010-0627-2
Research article (journal) | Published
Combined immunochemotherapy in selected patients with metastatic renal cell carcinoma: HLA class II genotype can help to predict response to therapy.
Bierer S, Hoffmeister I, Gerss J, Herrmann E, Wülfing C, Sibrowski W, Hertle L, Kelsch R (2011)
In: Journal of Immunotherapy, 34(2), 196-201.
Research article (journal) | Peer reviewed | Published
New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2.
Ciarimboli G, Holle SK, Vollenbröcker B, Hagos Y, Reuter S, Burckhardt G, Bierer S, Herrmann E, Pavenstädt H, Rossi R, Kleta R, Schlatter E (2011)
In: Molecular pharmaceutics, 8(1), 270-279.
Research article (journal) | Published
Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review.
Herrmann E, Trojan L, Becker F, Wülfing C, Schrader AJ, Barth P, Stöckle M, Hammerschmied CG, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Legal W, Wullich B, Bolenz C, Klein T, Noldus J, Bierer S, Hertle L, Brenner W, Roos F, Michel MS, Walter B, Wieland W, Gerss J, Otto W, Hartmann A (2010)
In: Journal of Urology, 183(2), 460-466.
Research article (journal) | Published
Update on systemic therapies of metastatic renal cell carcinoma.
Herrmann E, Bierer S, Wülfing C (2010)
In: World Journal of Urology, 28(3), 303-309.
Research article (journal) | Published
Show all publications